تداخل‌های دارویی
Certolizumab pegol + Ciltacabtagene autoleucel
شدت: شدید
Certolizumab pegol and Ciltacabtagene autoleucel: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
معنای این تداخل به زبان ساده
Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Certolizumab pegol belongs to Musculoskeletal; Ciltacabtagene autoleucel belongs to Miscellaneous.
چرا رخ می‌دهد
Additive immunosuppression from TNF blockade and CAR-T related lymphodepletion and cytopenias.
اقدام لازم
Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Certolizumab pegol و Ciltacabtagene autoleucel، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Certolizumab pegol
- Adenovirus types 4 and 7 live + Certolizumab pegol منع مصرف
- Bcg intravesical live + Certolizumab pegol منع مصرف
- Bcg vaccine live + Certolizumab pegol منع مصرف
- Certolizumab pegol + Influenza virus vaccine quadrivalent intranasal منع مصرف
- Certolizumab pegol + Measles mumps and rubella vaccine منع مصرف
- Certolizumab pegol + Measles mumps and rubella vaccine live منع مصرف
تداخلات دیگر Ciltacabtagene autoleucel
پرسش‌های متداول
Can I take Certolizumab pegol with Ciltacabtagene autoleucel?
MediHelp rates the interaction as major. Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
How serious is the interaction between Certolizumab pegol and Ciltacabtagene autoleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What other medicines interact with Certolizumab pegol?
MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
